04 Dic End-stage Renal Disease Market Growth Analysis, Size, Share, Report 2024-34
Market Overview:
The end-stage renal disease market reached a value of US$ 76.6 Billion in 2023 and expected to reach US$ 218.2 Billion by 2034, exhibiting a growth rate (CAGR) of 9.98% during 2024-2034. The end-stage renal disease market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the end-stage renal disease market.
Request for a Sample of this Report: https://www.imarcgroup.com/end-stage-renal-disease-market/requestsample
End-stage Renal Disease Market Trends:
End-stage renal disease (ESRD), also known as renal failure, marks the final stage of chronic kidney disease (CKD) when kidney function declines to critical levels. The ESRD market is driven by the rising prevalence of CKD worldwide, an aging population, and the growing incidence of diabetes, hypertension, and obesity—key contributors to kidney failure progression. The increasing demand for dialysis treatments, including hemodialysis and peritoneal dialysis, further fuels market growth as more individuals require these therapies.
Additionally, kidney transplants are gaining momentum due to advancements in surgical techniques and immunosuppressive therapies, improving outcomes for recipients. The market is also benefiting from the adoption of home-based dialysis options, such as home hemodialysis and automated peritoneal dialysis, which offer patients greater convenience and reduced hospital visits. Innovations in dialysis technologies, including wearable and portable devices, are enhancing patient comfort and outcomes, creating new growth opportunities in the market. Moreover, the development of novel therapies to slow CKD progression and improve patient quality of life, alongside the shift toward home-based care solutions, is expected to drive the ESRD market’s expansion during the forecast period.
Countries Covered:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country:
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the end-stage renal disease market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the end-stage renal disease market
- Reimbursement scenario in the market
- In-market and pipeline drugs
This report also provides a detailed analysis of the current end-stage renal disease market and late-stage pipeline drugs.
In-Market Drugs:
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Drug uptake and market performance
Competitive Landscape:
The competitive landscape of the end-stage renal disease market has been studied in the report with the detailed profiles of the key players operating in the market.
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7141&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Sin comentarios